Xing Y - Search Results

1

A novel EHD1/CD44/Hippo/SP1 positive feedback loop potentiates stemness and metastasis in lung adenocarcinoma.

Liu Y, Song Y, Cao M, Fan W, Cui Y, Cui Y, Zhan Y, Gu R, Tian F, Zhang S, Cai L, Xing Y. Liu Y, et al. Among authors: xing y. Clin Transl Med. 2022 Apr;12(4):e836. doi: 10.1002/ctm2.836. Clin Transl Med. 2022. PMID: 35485206 Free PMC article.

2

Survival analysis of patients with unilateral and bilateral primary breast cancer in Northeast China.

Xing Y, Meng Q, Sun L, Chen X, Cai L. Xing Y, et al. Breast Cancer. 2015 Sep;22(5):536-43. doi: 10.1007/s12282-014-0517-3. Epub 2014 Feb 8. Breast Cancer. 2015. PMID: 24510639

3

Expression of calcium sensing receptor and E-cadherin correlated with survival of lung adenocarcinoma.

Wen L, Sun L, Xi Y, Chen X, Xing Y, Sun W, Meng Q, Cai L. Wen L, et al. Among authors: xing y. Thorac Cancer. 2015 Nov;6(6):754-60. doi: 10.1111/1759-7714.12255. Epub 2015 Apr 24. Thorac Cancer. 2015. PMID: 26557914 Free PMC article.

4

TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.

Xing Y, Meng Q, Chen X, Zhao Y, Liu W, Hu J, Xue F, Wang X, Cai L. Xing Y, et al. Oncotarget. 2016 May 24;7(21):30479-91. doi: 10.18632/oncotarget.8586. Oncotarget. 2016. PMID: 27058415 Free PMC article.

5

FAT10 is associated with the malignancy and drug resistance of non-small-cell lung cancer.

Xue F, Zhu L, Meng QW, Wang L, Chen XS, Zhao YB, Xing Y, Wang XY, Cai L. Xue F, et al. Among authors: xing y. Onco Targets Ther. 2016 Jul 19;9:4397-409. doi: 10.2147/OTT.S98410. eCollection 2016. Onco Targets Ther. 2016. PMID: 27499634 Free PMC article.

6

Mammalian Eps15 homology domain 1 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition.

Meng Q, Xing Y, Ren T, Lu H, Xi Y, Jiang Z, Hu J, Li C, Sun L, Sun D, Cai L. Meng Q, et al. Among authors: xing y. Oncotarget. 2017 Apr 4;8(14):22433-22442. doi: 10.18632/oncotarget.11220. Oncotarget. 2017. PMID: 27531895 Free PMC article.

7

[Role of Hippo Signaling Pathway in Lung Cancer].

Liu Y, Xing Y, Cai L. Liu Y, et al. Among authors: xing y. Zhongguo Fei Ai Za Zhi. 2017 Sep 20;20(9):629-634. doi: 10.3779/j.issn.1009-3419.2017.09.07. Zhongguo Fei Ai Za Zhi. 2017. PMID: 28935017 Free PMC article. Review. Chinese.

8

TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.

Xing Y, Liu Y, Liu T, Meng Q, Lu H, Liu W, Hu J, Li C, Cao M, Yan S, Huang J, Wang T, Cai L. Xing Y, et al. Cell Commun Signal. 2018 Jul 31;16(1):43. doi: 10.1186/s12964-018-0254-x. Cell Commun Signal. 2018. PMID: 30064446 Free PMC article.

9

LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer.

Liu Y, Xing Y, Wang H, Yan S, Wang X, Cai L. Liu Y, et al. Among authors: xing y. Thorac Cancer. 2018 Dec;9(12):1725-1732. doi: 10.1111/1759-7714.12887. Epub 2018 Oct 1. Thorac Cancer. 2018. PMID: 30273983 Free PMC article.

10

PADI4‑mediated epithelial‑mesenchymal transition in lung cancer cells.

Liu M, Qu Y, Teng X, Xing Y, Li D, Li C, Cai L. Liu M, et al. Among authors: xing y. Mol Med Rep. 2019 Apr;19(4):3087-3094. doi: 10.3892/mmr.2019.9968. Epub 2019 Feb 19. Mol Med Rep. 2019. PMID: 30816464 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,490 results

Search Page

Filters